US2009054385A1PendingUtilityA1
Solid inhalation formulations of dehydroepiandrosterone derivatives
Est. expiryFeb 24, 2015(expired)· nominal 20-yr term from priority
Inventors:Jonathan W. Nyce
A61P 9/00A61P 43/00A61P 25/20A61K 31/519A61P 11/00A61P 11/06A61P 11/08A61K 45/06A61K 31/5685A61K 31/495A61K 31/50
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Solid pharmaceutical compositions and kits for administration to the lungs comprise a carrier and an agent for the treatment of bronchoconstriction and asthma, wherein the agent comprises a derivative of dehydroepiandrosterone having an SO2H or SO2Na group. The solid formulations can be administered as an aerosol.
Claims
exact text as granted — not AI-modified1 . A pharmaceutical composition for administration to the lungs, comprising a carrier and an amount of an active agent effective for treatment of bronchoconstriction, lung inflammation, lung allergy, or asthma wherein the active agent comprises a compound of formula (I), or pharmaceutically or veterinarily acceptable salts thereof,
wherein the broken line represents a single or double bond; R is hydrogen; and R 1 is SO 2 OM, wherein M is H or Na.
wherein the pharmaceutical composition comprises respirable dry solid particles formulated for administration as an aerosol.
2 . The pharmaceutical composition of claim 1 wherein particles are prepared by grinding the active agent and passing composition through a filter screen.
3 . The pharmaceutical composition of claim 2 wherein the particles are micronized.
4 . The pharmaceutical composition of claim 2 wherein the filter screen is a 400 mesh screen.
5 . The pharmaceutical composition of claim 1 further comprising a dispersant which serves to facilitate the formation of the aerosol.
6 . The pharmaceutical composition of claim 5 wherein the dispersant is lactose.
7 . The pharmaceutical composition of claim 1 wherein the active compound and the lactose are present at a ratio by weight of about 1 to 1.
8 . The pharmaceutical composition of claim 1 further comprising a surfactant.
9 . A kit comprising the formulation of claims 1 and a delivery device.
10 . The kit of claim 9 wherein the delivery device comprises a metered dose inhaler or an insufflator.Join the waitlist — get patent alerts
Track US2009054385A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.